once monthly glp 1 Injections of an ultra-long-acting investigational GLP-1 agonist led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER GLP-1/GIP Results After 1, 3,
Description
National Post reports generic semaglutide products could reach Canadian pharmacy shelves by summer 2026 as Health Canada reviews nine applications.
Starting a GLP-1 receptor agonist (GLP-1a) like Mounjaro, Ozempic, or Victoza can lead to meaningful improvements in blood sugar, weight, and appetite control
On the flipside, there are challenges: for example, concerns about cost to healthcare systems and equity of access for patients with the greatest unmet needs, or the possible impact on Medtech currently used by patients suffering from obesity related conditions for example knee replacements for overweight patients with eroded joints or CPAP machines for sleep apnoea, a complication of obesity
How she got into practice and how she got into the GLP-1 space
F45 y Dr
On GLP-1 meds
